Anti-Human RANKL Therapeutic Antibody (XPA 12 039)
Recombinant monoclonal antibody specifically binds to human RANKL and inhibits osteoclastogenesis. This antibody can effectively alleviate the apoptotic effects induced by TNF-a and against ovarian ablation induced osteoporosis model.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-306CT |
| Pricing | Inquiry |
| Host | Human |
| Target | RANKL |
| Species Reactivity | Human |
| Type | Human antibody |
| Applications | Used for immunoassay techniques such as: Western Blot; Enzyme-linked Immunosorbent Assay; Flow Cytometry; Blocking |